News2019-08-14T14:06:00+00:00

News

OcellO at AACR-NCI-EORTC Boston: Visit our booth #1628

OcellO team will be joining AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on the 26-30th October. We look forward to meeting with you ! If you like to set up a one-to-one meeting, you can reach us at [email protected] otherwise come by our booth #1628. Please follow the link for more information about this conference; https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=184

August 14th, 2019|

Press Release

OcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics ® programs LEIDEN, the Netherlands, March. 28, 2019 OcellO B.V., a Contract Research Organisation offering 3D cell based assay services for drug discovery to the pharmaceutical industry, today announced that it entered an agreement to provide in vitro research services to Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, for Merus’ MCLA-158 Biclonics® program and [...]

March 26th, 2019|

Hot off the press

Review article on drug screening and testing with 3D cell based assays LINK: https://journals.sagepub.com/doi/full/10.1177/2472555219830087?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

March 23rd, 2019|